Oxidative stress may predict later lung trouble in young adults

Certain measures of oxidant stress are positively associated with declines in lung function five years down the road, and those declines are indicative of the possible onset of lung disease such as chronic obstructive pulmonary disease (COPD).

Researchers used data from National Heart, Lung, and Blood Institute’s longitudinal cohort study, CARDIA (Coronary Artery Risk Development in Young Adults), which followed a more than 5,000 young adults between the ages of 18 and 30, assessing different markers of coronary health at two, five, seven, 10, 15 and 20 years from baseline.

In this analysis, investigators examined markers of oxidant stress, including oxidized low density lipoprotein (oxLDL), a modified form of LDL as a result of lipid peroxidation by oxygen free radicals, and F2-isopostanes, a by-product of oxidant-mediated destruction of cellular membranes, both measured in year 15 of the CARDIA study, and compared them to the lung function results in year 20 in almost 2,000 healthy adults.

“Our principle finding was that the highest levels of oxLDL at year 15 of the cohort were associated with the lowest forced expiratory volume in one second (FEV1) at year 20, which is a measure of airflow obstruction, one of the defining features of COPD and lower forced vital capacity (FVC), a measure of total lung capacity,” said Ravi Kalhan, M.D., M.S., assistant professor of medicine and director of the COPD program at Northwestern University Feinberg School of Medicine, senior author of the study. “In addition, individuals with highest levels of F2-isoprostaines had a trend towards having lower FEV¬¬¬1 and FVC.”

When they looked at these associations by gender, they found that they were markedly present in women, but not in men, which may be a step toward greater understanding of the gender disparity among COPD patients. “Women develop COPD more often than men, but we do not have a sense as to why,” explained Dr. Kalhan. “Exploring whether women have increased vulnerability to COPD or other lung diseases because of more oxidant stress could open the door to new therapies to modify the risk of developing the disease.”

The findings also may indicate a new way to predict and possibly prevent COPD in general. “We have not shown that oxidant markers can predict future COPD, [but] the association between their levels and lower lung function serves as a first step in determining whether they may be useful,” said Dr. Kalhan. “Because only the minority of smokers develop COPD, it would be a huge step forward if we could predict future development of COPD among individuals at risk.”

Source: American Thoracic Society

Smoking and solid fuel use in homes in China projected to cause millions of deaths
If current levels of smoking and biomass and coal fuel use in homes continues, between 2003 and 2033 there will be an estimated 65 million deaths from chronic obstructive pulmonary disease (COPD) and 18 million deaths from lung cancer in China, accounting for 19% and 5% of all deaths in that country during this period.
Creating lung cancer risk models for specific populations refines prediction
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research.
COPD? Eat your veggies
You know it's good for you in other ways, but could eating your broccoli also help patients with chronic lung disease? It just might.
Infection blocks lung's protective response against tobacco smoke
An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health. The findings, recently published online and scheduled to appear in the October issue of Infection and Immunity, suggest one mechanism that may cause smokers to develop chronic obstructive pulmonary disease.
No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD
Creatine, a popular nutritional supplement renowned for enhancing athletic performance and muscle strength, does not improve exercise outcomes in patients with chronic obstructive pulmonary disease (COPD), according to a new study. The randomized, placebo-controlled, double-blind study provided the most powerful evidence to date that the effect of creatine (Cr) supplementation was negligible at best among these patients.
Study shows why cigarette smoke makes flu, other viral infections worse
A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette smoke interact to increase lung inflammation and damage.
Guidelines for care of elderly patients ignored
Guidelines for the treatment of older patients with respiratory conditions are routinely ignored. Research published today in the open access journal BMC Health Services Research shows that recommended treatments are given to only a small minority of eligible patients.
Researchers find common gene disorder doubles risk of lung cancer, even among nonsmokers
Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers. The study is published in the May 26 issue of the Archives of Internal Medicine, a journal published by the American Medical Association.

Oxidative stress may predict later lung trouble in young adults

Related stories:

News discussion: